Eyestem

About:

Eyestem is a cell therapy company founded by a top-class management team.

Website: https://www.eyestem.com/

Twitter/X: EyestemResearch

Top Investors: Endiya Partners, Biological E., Alkem Laboratories, Kotak Private Equity, Impres Health

Description:

Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell therapy and ophthalmology experts. It also boasts a world class advisory board and we have built collaborations with pioneers and leaders in the space. Our long-term vision is to create a global and scalable cell therapy platform to treat incurable diseases. We are developing a cell therapy platform to produce consistent, quality products over the next few years, concentrating on in vitro efficacy and safety.

Total Funding Amount:

$6.83M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bengaluru, Karnataka, India

Founded Date:

2016-01-01

Contact Email:

info(AT)eyestem.com

Founders:

Dr. Jogin Desai, Jogin Desai, Rajani Battu

Number of Employees:

11-50

Last Funding Date:

2022-08-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai